Articles

Find an Article

Filter articles

Applied Filters

Showing 11 to 20 of 314 results

How to protect therapeutic methods in Brazil

Brazil20-05-2019Kene Gallois and Samantha Salim

Brazil’s patent law does not allow methods of treatment to be patented, but there are other means of getting protection, according to Kene Gallois and Samantha Salim of Daniel Law.

Algorithms—no; computer-implemented methods—yes

Mexico20-05-2019Alejandro Moreno Hernández

It is challenging but not impossible to protect software innovations in Mexico, according to Alejandro Moreno Hernández of Uhthoff, Gomez Vega & Uhthoff.

Conference preview: Reader offer to major US life sciences patents event

US09-05-2019Advice Connect Inspire

ACI’s 17th Global Summit on Life Sciences Patents returns to New York on May 15-17, 2019, to provide practical insights on how to maximise your patent term and develop strategies to enhance protections for your patent portfolio.

Politics and IP: an unhealthy mix

Brazil13-12-2018Gabriel Di Blasi

The political influence on patent rights during Brazil’s general election in October has set a worrying precedent, writes Gabriel Di Blasi of Di Blasi Parente & Associados.

How Mexico applies the Budapest Treaty

Mexico29-11-2018Hector Chagoya and Mariana Gonzalez-Vargas

Hector Chagoya and Mariana Gonzalez-Vargas of Becerril, Coca & Becerril examine how Mexico applies the Budapest Treaty, which covers microorganisms in the patent process.

Mexico: new links between patents and pharmaceuticals

Mexico12-11-2018Mariana Gonzalez-Vargas

A new facet of Mexico’s linkage system between patents and pharmaceutical drugs raises several questions that necessitate a careful approach from patent assignees and agents, as Mariana Gonzalez-Vargas of Becerril, Coca & Becerril reports.

Generic competition: when one door closes, another opens

EU, US26-10-2018

With several major drugs set to face generic or biosimilar competition as patent protection expires, LSIPR analyses how well prepared their manufacturers are and how badly their sales may be affected.

Mulling the future for marijuana IP

Canada, US24-10-2018

While cannabis companies in the US can’t protect their brands with federal trademark protection, there are other options for them when seeking IP rights, as LSIPR finds out.

The future of precision medicine part 3: translation from research to the clinic

UK, US23-10-2018Daniel Lim

The implementation of precision medicine represents a huge, possibly unprecedented, challenge to conventional clinical practice across the breadth of healthcare disciplines, says Daniel Lim of Kirkland & Ellis.

I-MAK: saving lives by curing the patent system

International, US19-10-2018

Non-profit organisation I-MAK is waging a global challenge against what it sees as invalid pharmaceutical patents, with access to life-saving drugs its main priority. LSIPR speaks to co-founder Tahir Amin to find out more.

Showing 11 to 20 of 314 results

LSIPR